Mereo BioPharma Group (MREO, $3.05) was a top loser this quarter, falling -19.53%

A.I.dvisor
at Tickeron.com
05/01/24
Loading...
MREO - Mereo BioPharma Group plc

Loading...

Price: $3.05
Daily change: +$0.29 (+10.51%)
Daily volume: 1.6M
3-month price change: -$0.74 (-19.53%)
Capitalization: $429.2M
Industry: Biotechnology
Mereo BioPharma Group (MREO, $3.05) was a top loser over the last three months, falling -1 to $3.05 per share. A.I.dvisor analyzed 914 stocks in the Biotechnology Industry for the 3-month period ending April 30, 2024, and found that of them (5) exhibited an Uptrend while of them (4) demonstrated a Downtrend.
View a ticker or compare two or three
MREODaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in therapeutics that aim to improve outcomes for patients with osteogenesis imperfecta, alpha-1 antitrypsin deficiency, hypogonadotropic hypogonadism in obese men, and acute exacerbations of chronic obstructive pulmonary disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Cavendish Place
Phone
+44 3330237300
Employees
33
Web
https://www.mereobiopharma.com